Othera Pharmaceuticals ^Company

Othera Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on treatments for ophthalmic diseases. Its products include OT-551 for geographic atrophy/dry age-related macular degeneration; OT-730 a small molecule oculoselective beta-blocker for reducing the elevated intraocular pressure associated with glaucoma; and OT-440, a neuroprotectant for glaucoma. The company was founded in 2002 and is headquartered in Exton, Pennsylvania.